Article Text

PDF
Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype
  1. C C Thorn1,
  2. T C Freeman2,
  3. N Scott3,
  4. P J Guillou1,
  5. D G Jayne1
  1. 1
    Department of Academic Surgery, St. James’s University Hospital, Leeds, UK
  2. 2
    Division of Pathway Medicine, College of Medicine, University of Edinburgh, UK
  3. 3
    Department of Pathology, St. James’s University Hospital, Leeds, UK
  1. Mr C C Thorn, Department of Academic Surgery, St. James’s University Hospital, Leeds, LS9 7TF, UK; christhorn77{at}yahoo.com

Abstract

Background: The morphology of the invasive margin in colorectal cancer can be described as either pushing or infiltrative. These phenotypes carry prognostic significance, particularly in node negative disease, and provide an excellent model for the study of invasive behaviour in vivo.

Methods: The marginal edges of 16 stage-matched tumours exhibiting these contrasting growth patterns were microdissected. The extracted mRNA was amplified and hybridised to a 9546 feature oligonucleotide array. Selected differentials were validated using real-time polymerase chain reaction and the protein product was interrogated by using immunohistochemistry.

Results: After stringent quality control and filtering of data generated, 39 genes were identified as being significantly differentially expressed between the two types of marginal edge. Several genes involved in cellular metabolism were identified as differentials including lactate dehydrogenase B (LDHB) and modulators of glucose transport.

Conclusions: The LDH expression profile differs between the invasive phenotypes. A hypothesis is proposed in which altered metabolism is a cause of contrasting invasive behaviour independent of the hypoxia-inducible factor mediated hypoxic response, consistent with the Warburg phenomenon.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Funding: I would like to thank the Medical Research Council who provided the microarrays through the Rosalind Franklin Centre for Genomic Research, Hinxton, Cambridge, UK.

  • Competing interests: None.

  • Ethics approval: Approval for this study was given by the Leeds Regional Ethics Committee on 21 January 2003 (reference LHA 02/318). Patient consent was obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Digest
    Robin Spiller Magnus Simren